Axis Bio
Axis Bio is a preclinical contract research organisation specializing in oncology, inflammation, and respiratory diseases. They focus on delivering high-quality research services with a culture of ownership and accountability, aiming to support clients in advancing their research and development efforts.
Industries
Nr. of Employees
small (1-50)
Axis Bio
Services
Protocol development, study execution and endpoint data collection for preclinical projects, with interpretive analysis for client reports.
Conduct of animal-based efficacy and tolerability studies, including management of tolerability issues and generation of data for publication or downstream development.
Provision of in vitro experimental services and cell-based testing to support mechanistic studies and preclinical data packages.
Flow cytometry-based analysis for cell phenotyping and immunological assays to quantify cellular responses in preclinical studies.
Training and mentoring of client personnel in welfare and handling practices to support reproducible and compliant in vivo research.
Protocol development, study execution and endpoint data collection for preclinical projects, with interpretive analysis for client reports.
Conduct of animal-based efficacy and tolerability studies, including management of tolerability issues and generation of data for publication or downstream development.
Provision of in vitro experimental services and cell-based testing to support mechanistic studies and preclinical data packages.
Flow cytometry-based analysis for cell phenotyping and immunological assays to quantify cellular responses in preclinical studies.
Training and mentoring of client personnel in welfare and handling practices to support reproducible and compliant in vivo research.
Expertise Areas
- Preclinical contract research
- In vivo pharmacology and efficacy testing
- In vitro assay development
- Flow cytometry and immunophenotyping
Key Technologies
- Flow cytometry
- Cell-based assays
- In vitro assay platforms
- In vivo animal models